Tumours that do not express ER, PR, or HER2—the triple negative phenotype (TNP) tumours—are often regarded as equivalent to the basal subtype as they can be easily identified with IHC markers that are currently used in routine clinical use. The gene discussed is ESR1; the disease is neoplasm.